Scientists from RUDN University with their colleagues from Yaroslavl have developed a new way to synthesize 1,2,4-oxadiazole derivatives used in many drugs. 1,2,4-oxadiazoles include ataluren, the active ingredient of a drug used in a treatment for genetic disorders. The results of the work are published in Tetrahedron Letters.